Mark James Litton Sells 4,820 Shares of Athira Pharma, Inc. (NASDAQ:ATHA) Stock
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 4,820 shares of the business’s stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $2.91, for a total value of $14,026.20. Following the sale, the chief executive officer now directly owns 144,397 […]
Mark James Litton Athira Pharma Wasatch Advisors Inc Dimensional Fund Advisors Athira Pharma Company Profile Metlife Investment Management
Source: etfdailynews.com